Anti-viral drug should not be first choice in treating COVID-19

3 December 2022 - The most widely prescribed anti-viral drug in Australia, molnupiravir, should no longer be routinely given for ...

Read more →

Hopes $55k breast cancer drug Keytruda will get PBS listing

3 December 2022 - Women with triple negative breast cancer have been given new hope that immunotherapy drug Keytruda will ...

Read more →

COVID-19 vaccine safety report (1 December 2022)

1 December 2022 - To 27 November 2022, the TGA has received 709 reports which have been assessed as likely to ...

Read more →

Agenda for the December 2022 PBAC intracycle meeting

2 December 2022 - The agenda for the December 2022 PBAC intracycle meeting is now available. ...

Read more →

Schedule of Pharmaceutical Benefits - 1 December 2022

1 December 2022 - The December 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

External consultation on the draft revised post-market review framework (deadline extension)

29 November 2022 - The Department of Health and Aged Care has received a request to extend the consultation period on ...

Read more →

Mepolizumab for the treatment of patients with eosinophilic granulomatosis with polyangiitis

29 November 2022 - The Department of Health and Social Care has asked NICE to produce guidance on the use of ...

Read more →

Type 2 diabetes drug shortage: Victoria’s Ozempic, Trulicity supplies limited until March

28 November 2022 - Type 2 diabetes sufferers are spending hours driving around the suburbs begging pharmacists for a drug that’s ...

Read more →

Croma Australia, a subsidiary of Hugel Aesthetics, receives TGA approval in Australia for Letybo (letibotulinumtoxinA) for the treatment of glabellar lines

28 November 2022 - Approval is supported by positive results from three completed Phase 3 trials that enrolled more than 1000 ...

Read more →

An open letter to doctors from the TGA

28 November 2022 - The TGA welcomes feedback and is committed to continuously improving processes and communications.  ...

Read more →

Cheaper medicines for high cholesterol and chronic heart failure

28 November 2022 - From 1 December 2022, Australians with high cholesterol, chronic heart failure, and a potentially life-threatening blood cell ...

Read more →

New prostate cancer treatment helping patients live longer, better

27 November 2022 - A treatment that could allow advanced prostate cancer patients to avoid chemotherapy and live longer has arrived ...

Read more →

Cost of life-saving heart disease drugs slashed, saving patients thousands

27 November 2022 - Life-saving medicines that tackle Australia's biggest killer are about to be added to the Pharmaceutical Benefits ...

Read more →

Hugel's 'Letybo' first in Korea to obtain marketing approval from Australia

 24 November 2022 - Obtained marketing approval on the 23rd (local time) from the TGA of Australia for the indication of ...

Read more →

Outcome in relation to discussion of COVID-19 oral treatments – November 2022 PBAC meeting

24 November 2022 - A PBAC outcome in relation to discussion of COVID-19 oral treatments at the November 2022 meeting has ...

Read more →